[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346425-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346425-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","esm1-and-protein-lysine-l-lactylation-modification-pan-kla-in-ovarian-cancer-coexpression-clinical-significance-and-prognostic-value","ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer - coexpression, clinical significance, and prognostic value","","Ovarian cancer remains a highly lethal malignancy, and endothelial cell-specific molecule 1 (ESM1) together with protein lysine L-lactylation modification (Pan-kla) are implicated in tumour microenvironment control via metabolic reprogramming, angiogenesis, and immune modulation. This study assessed ESM1 and Pan-kla in 131 ovarian cancer samples using immunohistochemistry, analysed clinical parameters and survival data, and applied Kaplan–Meier and risk stratification to determine coexpression patterns and prognostic significance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/esm1-and-protein-lysine-l-lactylation-modification-pan-kla-in-ovarian-cancer-coexpression-clinical-significance-and-prognostic-value/346425/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/esm1-and-protein-lysine-l-lactylation-modification-pan-kla-in-ovarian-cancer-coexpression-clinical-significance-and-prognostic-value/346425.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical and molecular roles do ESM1 and Pan-kla have in ovarian cancer according to this study?","Question",{"text":63,"@type":64},"ESM1 and Pan-kla are described as key regulators of the tumour microenvironment, involving metabolic reprogramming, angiogenesis, and immune modulation. The study focuses on how these factors relate to clinical outcomes and prognosis in ovarian cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were ESM1 and Pan-kla expression levels measured and analysed?",{"text":68,"@type":64},"Immunohistochemistry (IHC) was used to analyse ESM1 and Pan-kla expression in 131 ovarian cancer tissue samples. Survival was evaluated with Kaplan–Meier methods and risk stratification using R software.",{"name":70,"@type":61,"acceptedAnswer":71},"What prognostic impact was observed for ESM1 and Pan-kla coexpression?",{"text":72,"@type":64},"ESM1 and Pan-kla were both overexpressed and positively correlated. High expression of each biomarker was associated with worse outcomes, and patients with combined ESM1/Pan-kla expression were divided into four prognostic subgroups, with the dual-high group showing the poorest survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346425,1790146372,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Zhou et al. Diagnostic Pathology (2026) 21:14 [https://doi.org/10.1186/s13000-026-01748-0](https://doi.org/10.1186/s13000-026-01748-0)  \nDiagnostic Pathology  \nRESEARCH Open Access  \nESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer:  \ncoexpression, clinical significance, and prognostic value  \nWenchao Zhou1,2†, Yang Zhou3†, Tian Zeng2†, Zhenqin Gao1, Yi Deng1, Yukun Li2* and Xiyun Quan1*  \nAbstract  \nBackground Ovarian cancer (OC) remains a highly lethal gynaecologic malignancy. Endothelial cell-specific molecule 1 (ESM1) and protein lysine L-lactylation modification (Pan-kla) are key players in tumour microenvironment regulation, which involves metabolic reprogramming, angiogenesis, and immune modulation. However, their coexpression patterns, clinical relevance, and synergistic prognostic impact in OC patients have not been fully elucidated.  \nMethods In this study, immunohistochemistry (IHC) was used to analyse ESM1 and Pan-kla expression in 131 ovarian cancer tissue samples from patients diagnosed between 2014 and 2024. Clinical parameters (e. g., FIGO stage, CA125 level, and ascites) and survival data were collected. Statistical analyses, including Kaplan–Meier survival and risk stratification, were performed using R software.  \nResults ESM1 and Pan-kla were significantly overexpressed in OC tissues, with a strong positive correlation  \n(P \u003C 0. 0001) . High expression of both biomarkers was associated with adverse clinical features: advanced FIGO stage, elevated CA125 levels, and malignant ascites. Survival analysis revealed that high ESM1 expression increased the risk of death, whereas high Pan-kla expression increased the risk. Patients exhibiting combined ESM1/Pan-kla expression were stratified into four prognostic subgroups, with the dual-high group exhibiting the worst survival (P \u003C 0. 001) . Conclusion ESM1 and Pan-kla synergistically promote OC progression through metabolic–epigenetic crossregulatory mechanisms. Their combined assessment provides robust prognostic stratification and reveals potential targets for overcoming therapeutic resistance in ovarian cancer.  \nKeywords ESM1, Pan-kla, Ovarain cancer, Diagnostic biomarker  \n†Wenchao Zhou, Yang Zhou and Tian Zeng contributed equally to this work.  \n*Correspondence: Yukun Li  \n[yukun_li@foxmail.com](yukun_li@foxmail.com); [yukun_li@csu.edu.cn](yukun_li@csu.edu.cn)  \nXiyun Quan  \n[quanxiyun@aliyun.com](quanxiyun@aliyun.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nZhou et al. Diagnostic Pathology (2026) 21:14 Page 2 of 10  \nGraphical Abstract  \nIntroduction  \nOvarian cancer remains among the most lethal gynaecologic malignancies, with epithelial ovarian cancer (EOC) accounting for approximately 90% of cases [1]. Despite advancements in surgical cytoreduction and platinumbased ch","cbCaijUEhRGHaaqu","https://ap.wps.com/l/cbCaijUEhRGHaaqu","pdf",2078442,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epithelial ovarian cancer and prognosis\n## ESM1 in the tumour microenvironment\n## Previous findings across diseases","[{\"question\":\"What clinical and molecular roles do ESM1 and Pan-kla have in ovarian cancer according to this study?\",\"answer\":\"ESM1 and Pan-kla are described as key regulators of the tumour microenvironment, involving metabolic reprogramming, angiogenesis, and immune modulation. The study focuses on how these factors relate to clinical outcomes and prognosis in ovarian cancer.\"},{\"question\":\"How were ESM1 and Pan-kla expression levels measured and analysed?\",\"answer\":\"Immunohistochemistry (IHC) was used to analyse ESM1 and Pan-kla expression in 131 ovarian cancer tissue samples. Survival was evaluated with Kaplan–Meier methods and risk stratification using R software.\"},{\"question\":\"What prognostic impact was observed for ESM1 and Pan-kla coexpression?\",\"answer\":\"ESM1 and Pan-kla were both overexpressed and positively correlated. High expression of each biomarker was associated with worse outcomes, and patients with combined ESM1/Pan-kla expression were divided into four prognostic subgroups, with the dual-high group showing the poorest survival.\"}]","ESM1 and protein lysine L-lactylation modification (Pan-kla) in ovarian cancer - coexpression, clinical significance, and prognostic value | PDF",1790061410,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8879e82eb6437c348da0de52626c5f2.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77a3fb245fdeff41e5962b474a15da6c.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a88be35d07141bf6849a193ef1dde16.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3527e9f9d2b18dfa5a5f50fa44dec307.webp",980,1306]